Charlotte Schubert (@schubertcm) writes for GeekWire about the legacy of cellular therapy company Juno Therapeutics (now a Bristol Myers Squibb company) on the Seattle biotech scene (and beyond). The Seattle company launched in 2013, bolstering the region’s reputation as a cellular therapy powerhouse and opening the floodgates of capital investment in subsequent life sciences companies, which thrived on the expertise, leadership and relationships originally cultivated by Juno.
